MemorialCare Innovation Fund contributed to a series D round that brought the heart valve technology developer's overall funding to more than $36m.
Foldax, a US-based producer of biopolymer heart valve implants, completed a $20m series D round led by healthcare provider MemorialCare’s Innovation Fund yesterday.
The round included California Institute of Technology (Caltech), Angel Physicians Fund, investment firm BioStar Capital and venture capital firms Kairos Ventures and Sayan Bioventures.
Founded in 2014, Foldax designs and manufactures artificial heart valve implants made from biopolymers to prevent the build-up of calcium deposits in the body.
The company will use the cash to boost enrolment…
